Rosetrees funded scientists have developed a novel cancer therapy that uses MRI to remotely-control magnetic agents that target and destroy hard -to-reach tumours.
This new therapy developed by Professor Mark Lythgoe’s group at UCL is called “minimally invasive image-guided ablation” or MINIMA. The therapy uses magnetic balls, guided by MRI, generating heat that destroys the tumour without damaging nearby tissue. This proof-of-concept study, published in Advanced Science, is an exciting potential breakthrough for treating a range of hard-to-treat cancers without the need for invasive surgery.
For full details of the paper published please click the link.